Literature DB >> 9044504

Classification of the posttransplant lymphoproliferative disorders: from the past to the present.

S H Swerdlow1.   

Abstract

Posttransplant lymphoproliferative disorders (PTLD) represent a histopathologic, immunophenotypic, genotypic, and clinical spectrum of disease seen in patients after solid organ and bone marrow transplantation. Because of their great heterogeneity, several classification schemes have been proposed over the past 15 years. Although originally based on morphology and limited immunophenotypic studies, more detailed immunophenotypic and genotypic studies have become increasingly important in the classification of the PTLD. The classifications proposed by Frizzera et al, Nalesnik et al, and Knowles et al are discussed. In addition, some specific types of PTLD recognized in the literature but not distinguished in any of the currently published classifications are presented.

Entities:  

Mesh:

Year:  1997        PMID: 9044504

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  5 in total

1.  A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

Authors:  Susan P Perrine; Olivier Hermine; Trudy Small; Felipe Suarez; Richard O'Reilly; Farid Boulad; Joyce Fingeroth; Melissa Askin; Arthur Levy; Steven J Mentzer; Massimo Di Nicola; Alessandro M Gianni; Christoph Klein; Steven Horwitz; Douglas V Faller
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

Review 2.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Post-transplant lymphoproliferative disorders.

Authors:  K J Lewin
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

5.  Lymph Node Flow Cytometry as a Prompt Recognition of Ultra Early Onset PTLD: A Successful Case of Rituximab Treatment.

Authors:  Xiaofan Li; Nainong Li; Ting Yang; Zhizhe Chen; Jianda Hu
Journal:  Case Rep Hematol       Date:  2015-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.